Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Failure to induce clinical response at end of study · Patients with moderately to severely active ulcerative colitis

Vedolizumab probably leads to lower failure to induce clinical response compared with placebo (moderate certainty).

1 finding from 1 review

Vedolizumab for induction and maintenance of remission in ulcerative colitis 2014 · Cochrane Headline outcomes only
RR 0.68 [0.59, 0.78]
3 studies · 601 participants
Moderate